Latest Breaking News On - Monica kozlowski - Page 1 : comparemela.com

Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer Research Conference

COLUMBUS, Ohio, Sept. 05, 2023 (GLOBE NEWSWIRE) Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovati.

United statesBarry kommPaul plourdeSimon jenkinsMonica kozlowskiEli lillyDavid portmanElizabeth attiasMiriam portmanParke davis pharmaceuticalsAmerican society of clinical oncologyLigand pharmaceuticals incSermonix pharmaceuticals incMetastatic breast cancer research conferenceDuke universitySermonix pharmaceuticals

Sermonix Pharmaceuticals to Present Two Posters at The Menopause Society 2023 Annual Meeting

Sermonix Pharmaceuticals to Present Two Posters at The Menopause Society 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMonica kozlowskiBarry kommPaul plourdeElisa larkinSimon jenkinsDavid portmanElizabeth attiasMiriam portmanAmerican menopause societyMenopause society annual meetingSermonix pharmaceuticals incCorporate liaison councilSermonixsermonix pharmaceuticals incLigand pharmaceuticals incMidlife women health

Sermonix Pharmaceuticals to Share Longer Patient Follow-up Results for ELAINE-2 in Poster Presentation at ASCO 2023

Sermonix Pharmaceuticals to Share Longer Patient Follow-up Results for ELAINE-2 in Poster Presentation at ASCO 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMccormick placeMonica kozlowskiMiriam portmanBarry kommSimon jenkinsElizabeth attiasEli lillyDavid portmanPaul plourdeLigand pharmaceuticals incTranslational committeeParke davis pharmaceuticalsSermonixsermonix pharmaceuticals incSermonix pharmaceuticals incSermonix pharmaceuticals

Sermonix Pharmaceuticals Announces Four Abstracts Accepted for Presentation at 2022 San Antonio Breast Cancer Symposium

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative targeted therapeutics to specifically treat ESR1-mutated

United statesSan antonioPaul plourdeElizabeth attiasMonica kozlowskiGlenn garmontMiriam portmanSimon jenkinsDavid portmanBarry kommLigand pharmaceuticals incSociety lifestyleHealthcare pharmaceuticals industryParke davis pharmaceuticalsSermonix pharmaceuticals incHenryb gonzalez convention center

Sermonix Pharmaceuticals Announces Four Abstracts Accepted

COLUMBUS, Ohio, Nov. 17, 2022 (GLOBE NEWSWIRE) Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative.

United statesSan antonioPaul plourdeElizabeth attiasMonica kozlowskiGlenn garmontMiriam portmanSimon jenkinsDavid portmanBarry kommLigand pharmaceuticals incParke davis pharmaceuticalsSermonix pharmaceuticals incHenryb gonzalez convention centerDuke universityInvestor relations corporate communications